OraSure Technologies Inc. (OSUR)

NASDAQ: OSUR · Real-Time Price · USD

2.93

-0.06 (-2.01%)

At close: May 01, 2025, 3:59 PM

2.94

0.30%

After-hours: May 01, 2025, 04:20 PM EDT

-2.01% (1D)

Bid	2.83
Market Cap	227.13M
Revenue (ttm)	108.77M
Net Income (ttm)	-8.72M
EPS (ttm)	-0.26
PE Ratio (ttm)	-11.27
Forward PE	-8.09
Analyst	Hold

Ask	3.1
Volume	196,590
Avg. Volume (20D)	756,929
Open	2.98
Previous Close	2.99
Day's Range	2.90 - 3.04
52-Week Range	2.69 - 5.59
Beta	0.77

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test...

Sector Healthcare

IPO Date Nov 17, 1986

Employees 501

Stock Exchange NASDAQ

Ticker Symbol OSUR

Website https://www.orasure.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 87.64% from the latest price.

Stock Forecasts

Next Earnings Release

OraSure Technologies Inc. is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 month ago

+6.4%

OraSure Technologies shares are trading higher aft... Unlock content with Pro Subscription

2 months ago

-23.5%

OraSure Technologies shares are trading lower after the company issued Q1 revenue guidance below estimates.

News

1 day ago · seekingalpha.com

OraSure Technologies: Historically Cheap

OraSure Technologies shares have dipped below $3 since my last writing, making shares even cheaper. Recent developments at the company include the acquisition of Sherlock Biosciences and the announcem...

2 months ago · seekingalpha.com

OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript

OraSure Technologies, Inc. (NASDAQ:OSUR ) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ET Company Participants Jason Plagman - VP of Investor Relations Carrie Eglinton Manner - President ...

2 months ago · zacks.com

OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates

OraSure Technologies (OSUR) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.22 per share a year ago.